World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
30303
World Ranking
12192
National Ranking
6252

Research.com Recognitions

  • 2002 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Elise C. Kohn is affiliated with the National Institutes of Health in the United States. Their principal area of research lies within medicine, with a specific emphasis on oncology, reproductive medicine, epidemiology, neurology, and molecular biology. The scientist has contributed extensively to topics related to ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, neuroendocrine tumor research advances, lung cancer research studies, neuroblastoma research and treatments, endometrial and cervical cancer treatments, and BRCA gene mutations in cancer.

Their recent scholarly contributions include papers published between 2020 and 2022, reflecting ongoing engagement with clinical oncology and cancer therapeutics. Notable recent papers include:

  • Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline (2020) published in Journal of Clinical Oncology
  • PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline (2020) published in Journal of Clinical Oncology
  • Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial (2020) published in The Lancet Oncology
  • Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup (2022) published in The Lancet Oncology
  • Poly(ADP-Ribose) Polymerase Inhibitors in the Management of Ovarian Cancer: ASCO Guideline Rapid Recommendation Update (2022) published in Journal of Clinical Oncology

Frequent co-authors collaborating with Elise C. Kohn include:

  • S. Percy Ivy
  • Joyce F. Liu
  • Larry Rubinstein
  • William P. Tew
  • Michael A. Bookman

Publications by Elise C. Kohn appear regularly in several prominent scientific journals, indicating areas of consistent scholarly focus. These publication venues include:

  • Journal of Clinical Oncology
  • Gynecologic Oncology
  • Annals of Oncology
  • JNCI Journal of the National Cancer Institute
  • Cancer

Elise C. Kohn's research primarily addresses challenges in ovarian cancer and related gynecologic malignancies, with an emphasis on molecular therapeutics such as PARP inhibitors.

In recognition of their scientific contributions, Kohn was honored as a Fellow of the American Association for the Advancement of Science (AAAS) in 2002.

Best Publications

  • The microenvironment of the tumour-host interface

    Lance A. Liotta;Elise C. Kohn

  • The MAPK pathway across different malignancies: a new perspective.

    Mauricio Burotto;Victoria L. Chiou;Jung-Min Lee;Elise C. Kohn

  • Serum Proteomic Patterns for Detection of Prostate Cancer

    Emanuel F. Petricoin;David K. Ornstein;Cloud P. Paweletz;Ali Ardekani

  • Molecular Insights into Cancer Invasion: Strategies for Prevention and Intervention

    Elise C. Kohn;Lance A. Liotta

  • Clinical proteomics: translating benchside promise into bedside reality

    Emanuel F. Petricoin;Kathryn C. Zoon;Elise C. Kohn;J. Carl Barrett

  • Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study

    Joyce F. Liu;William T. Barry;Michael Birrer;Jung Min Lee

  • Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer

    Monica Brown Jones;Henry Krutzsch;Hungjun Shu;Yingming Zhao

  • Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity

    Nilofer S. Azad;Edwin M. Posadas;Virginia E. Kwitkowski;Seth M. Steinberg

  • PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies

    Lee Jm;Ledermann Ja;Kohn Ec

  • Angiogenesis: role of calcium-mediated signal transduction.

    Elise C. Kohn;Riccardo Alessandro;Joseph Spoonster;Robert P. Wersto

  • Extracellular matrix promotes mammary epithelial growth and differentiation in vitro.

    Max S. Wicha;George Lowrie;Elise Kohn;P. Bagavandoss

  • High-resolution serum proteomic features for ovarian cancer detection.

    T P Conrads;V A Fusaro;S Ross;D Johann

  • Clinical proteomics: personalized molecular medicine.

    Lance A. Liotta;Elise C. Kohn;Emanuel F. Petricoin

  • Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors.

    Osama M. El-Badry;Caterina Minniti;Elise C. Kohn;Peter J. Houghton

  • What's in the 'BAG'?--A functional domain analysis of the BAG-family proteins.

    Howard Doong;Alysia Vrailas;Elise C. Kohn

  • Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a src-dependent fashion

    Marco Mineo;Marco Mineo;Susan H. Garfield;Simona Taverna;Anna Flugy

  • Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I Study

    Jung Min Lee;Ashley M Cimino-Mathews;Cody J. Peer;Alexandra Zimmer

  • Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.

    Panagiotis A. Konstantinopoulos;Barbara Norquist;Christina Lacchetti;Deborah Armstrong

  • Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer.

    Elise C. Kohn;Gisele Sarosy;Annette Bicher;Charles Link

  • Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer.

    G Sarosy;E Kohn;D A Stone;M Rothenberg

Frequent Co-Authors

Lance A. Liotta
Lance A. Liotta George Mason University
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
William D. Figg
William D. Figg National Institutes of Health
Eddie Reed
Eddie Reed National Institutes of Health
Riccardo Alessandro
Riccardo Alessandro University of Palermo
Ursula A. Matulonis
Ursula A. Matulonis Harvard University
Ben Davidson
Ben Davidson Oslo University Hospital
Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
Michael J. Birrer
Michael J. Birrer University of Arkansas for Medical Sciences
Emanuel F. Petricoin
Emanuel F. Petricoin George Mason University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine goes beyond becoming a physician. Many allied health roles and advanced degrees can be accessed through flexible online programs. For nurses aiming for leadership or advanced clinical roles, best online dnp programs provide a path to the highest level of nursing practice, often with affordable options for working professionals.

Students interested in pharmacy can benefit from the cheapest online pharmacy school programs, making pharmacy careers more accessible and cost-effective. For those fascinated by the intersection of healthcare and technology, pursuing a degree in health informatics can open doors to managing medical data, electronic health records, and improving healthcare efficiency.

If you're interested in the business side of medicine, there are also affordable medical billing and coding online courses cost options, which provide in-demand skills for administrative healthcare roles. These career pathways offer diverse opportunities for those passionate about healthcare, even outside of traditional medical school.

Best Scientists Citing Elise C. Kohn

Trending Scientists

Recently Published Articles